|
Volumn 333, Issue 6047, 2011, Pages 1216-1218
|
Reinventing project BioShield
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRAX VACCINE;
EBOLA VACCINE;
VACCINE;
LITERATURE REVIEW;
PROJECT ASSESSMENT;
THEORETICAL STUDY;
BIOLOGICAL WARFARE;
BIOSAFETY;
CLINICAL PROTOCOL;
DRUG INDUSTRY;
DRUG MARKETING;
FUNDING;
HEALTH CARE PERSONNEL;
HUMAN;
INVESTMENT;
LAW;
PRIORITY JOURNAL;
PROGRAM DEVELOPMENT;
PUBLIC HEALTH SERVICE;
SHORT SURVEY;
UNITED STATES;
VACCINATION;
VACCINE PRODUCTION;
BIOTECHNOLOGY;
ECONOMICS;
GOVERNMENT;
NOTE;
ORGANIZATION AND MANAGEMENT;
ANTHRAX VACCINES;
BIOLOGICAL WARFARE;
BIOTECHNOLOGY;
BIOTERRORISM;
DRUG INDUSTRY;
HUMANS;
UNITED STATES;
UNITED STATES DEPARTMENT OF DEFENSE;
UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;
VACCINES;
|
EID: 80052482683
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.333.6047.1216 Document Type: Short Survey |
Times cited : (7)
|
References (0)
|